| Heading: |
Obesity: Drugs and Exercise |
| Question ID: |
1805075 |
| UIN: |
54057 |
| House: |
Commons |
| Date tabled: |
2025-05-21 |
| Asking Member ID: |
5055 |
| Asking Member display name: |
Max Wilkinson
|
| Asking Member handle: |
mpmwilko
|
| Asking Member Twitter reference: |
@mpmwilko
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what plans he has to ensure healthcare practitioners prescribe exercise when weight loss injections are prescribed for anti-obesity treatment. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-06 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Weight loss drugs, including semaglutide, tirzepatide and liraglutide, are recommended by the National Institute for Health and Care Excellence (NICE) as clinically and cost-effective treatment options on the National Health Service for obesity. The guida... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |